Agentix Corp.

AGTX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014
Operating Activities
Net Income $-381.1K $-295.6K $-175.1K $-208.9K
Depreciation & Amortization — — — —
Depreciation $264 $264 $198 $198
Amortization — $189 $189 $231
Stock-Based Compensation — — — —
Net Cash from Operating Activities $-76.4K $-12.6K $-186.9K $-193.9K
Investing Activities
Capital Expenditures — — — $1.3K
Business Acquisitions — — — —
Net Cash from Investing Activities $-9.5K — — $-5.1K
Financing Activities
Dividends Paid — — — —
Stock Repurchases — — — —
Net Cash from Financing Activities $89.0K — $65.3K $252.0K
Net Change in Cash $3.1K $-12.6K $-121.6K $53.0K
Free Cash Flow — — — $-195.2K
← Newer Page 2 of 2 Older →